Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?

Shapiro AD, McDaniel H, Decker RW, Nakar C, Lorber J, Thukral N, Parker JM, Thibaudeau K

Open source

DOI
10.1177/20406207261463031
Published
2026
Container
Therapeutic advances in hematology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20406207261463031,
  title = {Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?},
  author = {Shapiro AD and McDaniel H and Decker RW and Nakar C and Lorber J and Thukral N and Parker JM and Thibaudeau K},
  year = {2026},
  journal = {Therapeutic advances in hematology},
  doi = {10.1177/20406207261463031},
  url = {https://doi.org/10.1177/20406207261463031}
}

RIS

TY  - JOUR
TI  - Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?
AU  - Shapiro AD
AU  - McDaniel H
AU  - Decker RW
AU  - Nakar C
AU  - Lorber J
AU  - Thukral N
AU  - Parker JM
AU  - Thibaudeau K
PY  - 2026
JO  - Therapeutic advances in hematology
DO  - 10.1177/20406207261463031
UR  - https://doi.org/10.1177/20406207261463031
ER  - 

APA

AD, S., H, M., RW, D., C, N., J, L., N, T., JM, P., & K, T. (2026). Plain language summary: How safe and effective is long-term treatment with intravenous plasminogen concentrate for people with type 1 plasminogen deficiency?. Therapeutic advances in hematology. https://doi.org/10.1177/20406207261463031

Source records